125 related articles for article (PubMed ID: 24189498)
21. Formulation considerations for dry powder inhalers.
Cordts E; Steckel H
Ther Deliv; 2014 Jun; 5(6):675-89. PubMed ID: 25090281
[TBL] [Abstract][Full Text] [Related]
22. Emerging drugs for the treatment of tuberculosis.
Yew WW; Cynamon M; Zhang Y
Expert Opin Emerg Drugs; 2011 Mar; 16(1):1-21. PubMed ID: 20868293
[TBL] [Abstract][Full Text] [Related]
23. [An update on the antibiotic therapy of tuberculosis].
Rossi G
Recenti Prog Med; 1999 May; 90(5):241-3. PubMed ID: 10380549
[No Abstract] [Full Text] [Related]
24. [Treatment and diagnostics of tuberculosis: moving slowly forward].
Andersen AB; Lillebæk T; Bang D; Prahl J
Ugeskr Laeger; 2011 Mar; 173(12):897-9. PubMed ID: 21419061
[TBL] [Abstract][Full Text] [Related]
25. Delayed death from pulmonary tuberculosis: unsuspected subtherapeutic drug levels.
Morehead RS
South Med J; 2000 May; 93(5):507-10. PubMed ID: 10832953
[TBL] [Abstract][Full Text] [Related]
26. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
[TBL] [Abstract][Full Text] [Related]
27. [Managing the adverse events of antitubercular agents].
Perriot J; Chambonnet E; Eschalier A
Rev Mal Respir; 2011 Apr; 28(4):542-55. PubMed ID: 21549908
[TBL] [Abstract][Full Text] [Related]
28. Formulation strategy and use of excipients in pulmonary drug delivery.
Pilcer G; Amighi K
Int J Pharm; 2010 Jun; 392(1-2):1-19. PubMed ID: 20223286
[TBL] [Abstract][Full Text] [Related]
29. Delivery of antibiotics to the respiratory tract: an update.
Traini D; Young PM
Expert Opin Drug Deliv; 2009 Sep; 6(9):897-905. PubMed ID: 19637984
[TBL] [Abstract][Full Text] [Related]
30. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
Kononets AS
Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
[TBL] [Abstract][Full Text] [Related]
31. Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study.
Stass H; Weimann B; Nagelschmitz J; Rolinck-Werninghaus C; Staab D
Clin Ther; 2013 Oct; 35(10):1571-81. PubMed ID: 24054830
[TBL] [Abstract][Full Text] [Related]
32. [Personal experience in the antibiotic therapy of pulmonary tuberculosis].
Zapatero Domínguez DJ
An R Acad Nac Med (Madr); 1978; 95(2):155-93. PubMed ID: 354426
[No Abstract] [Full Text] [Related]
33. Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients.
Westerman EM; Heijerman HG; Frijlink HW
Expert Opin Drug Deliv; 2007 Mar; 4(2):91-4. PubMed ID: 17335406
[TBL] [Abstract][Full Text] [Related]
34. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
35. [Efficacy of chemotherapy in patients with the newly detected complicated destructive pulmonary tuberculosis].
Mishin VIu; Kazennyĭ BIa; Khoroshutina VV
Probl Tuberk Bolezn Legk; 2004; (6):17-9. PubMed ID: 15315124
[TBL] [Abstract][Full Text] [Related]
36. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
Li X; Vogt FG; Hayes D; Mansour HM
Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
[TBL] [Abstract][Full Text] [Related]
37. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP
Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315
[TBL] [Abstract][Full Text] [Related]
38. Current status and future prospects for new therapies for pulmonary tuberculosis.
de Souza MV
Curr Opin Pulm Med; 2006 May; 12(3):167-71. PubMed ID: 16582670
[TBL] [Abstract][Full Text] [Related]
39. New ways of insulin delivery.
Heinemann L
Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
[TBL] [Abstract][Full Text] [Related]
40. Dry powder inhalers for pulmonary drug delivery.
Frijlink HW; De Boer AH
Expert Opin Drug Deliv; 2004 Nov; 1(1):67-86. PubMed ID: 16296721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
